News Sentiment

MD sentiment intelligence

Mednax Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 15 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Care Facilities Read-through group
Latest close 26.27 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Earnings

72/100 classification confidence.

Company focus 15

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-1.8% over one week, +8.1% over four weeks, trend active, and materially above fair value.

Latest direct headline Negative

Pediatrix reaffirms $280–$300 million EBITDA outlook

Market Reaction

Balanced read

60/100 confidence

News tone and price action are not far from neutral.

Primary event Earnings 72/100 classification
One-week reaction -1.8% Price digesting
Trend fit Trend active 8.1% over four weeks
Fair value 81.9% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 10
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 15
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 3
Stock Titan 2
www.marketscreener.com 2
grafa.com 1
Yahoo! Finance Canada 1
Simply Wall Street 1
MarketBeat 1
AD HOC NEWS 1

Event Lens

What the news is about

Classified themes
Earnings 5
Market update 5
Guidance 2
Deals and strategy 1
Balance sheet 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-15 of 15
grafa.com Direct company coverage

Pediatrix reaffirms $280–$300 million EBITDA outlook

Pediatrix Medical Group (NYSE:MD) has reaffirmed its 2026 Adjusted EBITDA outlook of $280–$300 million, despite other healthcare companies reporting unfavorable shifts. The company stated its second-quarter payor mix remained stable, matching historical trends and internal expect

Tone
Negative 34/100
Event
Guidance
Published
15 Jul 2026 11:13
Source
grafa.com
Stock Titan Direct company coverage

Pediatrix Medical Group (NYSE: MD) keeps 2026 EBITDA view as payor mix holds

Pediatrix Medical Group (NYSE: MD) has reaffirmed its full-year 2026 Adjusted EBITDA outlook of $280 million to $300 million, stating that its second-quarter 2026 payor mix remained stable despite adverse trends reported elsewhere in the healthcare sector. The company also confir

Tone
Positive 66/100
Event
Guidance
Published
15 Jul 2026 11:11
Source
Stock Titan
Yahoo! Finance Canada Direct company coverage

Pediatrix Medical Group Provides Second Quarter Update

Pediatrix Medical Group, Inc. (NYSE: MD) provided an update on its second-quarter 2026 business trends, confirming that its payor mix remained stable and it has not experienced unfavorable payor mix shifts reported by other healthcare participants. The company reaffirmed its full

Tone
Neutral 50/100
Event
Earnings
Published
15 Jul 2026 11:11
Source
Yahoo! Finance Canada
Stock Titan Direct company coverage

Pediatrix Medical Group (NYSE: MD) 5.1% stake held via Dimensional funds

Dimensional Fund Advisors LP has disclosed a significant stake in Pediatrix Medical Group Inc. (NYSE: MD), beneficially owning 4,220,311 shares, which represents 5.1% of the outstanding common stock. The filing, a SCHEDULE 13G, indicates Dimensional holds sole voting power over 4

Tone
Neutral 50/100
Event
Deals and strategy
Published
14 Jul 2026 17:10
Source
Stock Titan
Simply Wall Street Direct company coverage

Does Pediatrix (MD) Joining Russell Defensive Indexes Recast Its Profile as a Value-Safe Haven?

Pediatrix Medical Group (NYSE: MD) was recently added to the Russell 2000 Value-Defensive Index and the Russell 2000 Defensive Index, a move that could broaden its investor base and trading liquidity. While this inclusion suggests a perception of the company as a defensive health

Tone
Neutral 50/100
Event
Balance sheet
Published
03 Jul 2026 03:40
Source
Simply Wall Street
www.marketscreener.com Direct company coverage

Pediatrix Medical Group, Inc.(NYSE: MD) added to Russell 2000 Defensive Index

Pediatrix Medical Group, Inc. (NYSE: MD) has been added to the Russell 2000 Defensive Index. This news follows several recent updates for the company, including UBS adjusting its price target and the release of their Q1 2026 earnings report, which showed increased adjusted earnin

Tone
Positive 70/100
Event
Earnings
Published
29 Jun 2026 03:10
Source
www.marketscreener.com
www.marketscreener.com Direct company coverage

Pediatrix Medical Group, Inc.(NYSE: MD) added to Russell 2000 Value-Defensive Index

Pediatrix Medical Group, Inc. (NYSE: MD) has been added to the Russell 2000 Value-Defensive Index. This announcement highlights the company's inclusion in a significant market index, reflecting its established presence in the healthcare sector. The article also provides recent ne

Tone
Positive 66/100
Event
Market update
Published
29 Jun 2026 02:12
Source
www.marketscreener.com
TradingView Direct company coverage

Enterprise value to EBITDA forward of Pediatrix Medical Group, Inc. – NYSE:MD

This article provides financial data specifically focusing on the "Enterprise value to EBITDA forward" for Pediatrix Medical Group, Inc. (NYSE: MD). The content appears to be a stub or a data point from a financial platform like TradingView, indicating no available value or chang

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 02:09
Source
TradingView
TradingView Direct company coverage

Pediatrix Medical Group, Inc. Actuals & Estimates (NYSE:MD)

This article provides key financial data and analyst estimates for Pediatrix Medical Group, Inc. (NYSE:MD). It covers the company's stock performance, market capitalization, earnings, revenue, and future outlook based on analyst forecasts, as well as general information for poten

Tone
Positive 70/100
Event
Earnings
Published
25 Jun 2026 15:39
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Pediatrix Medical Group, Inc. – NYSE:MD

This article provides the "Price to earnings forward" value for Pediatrix Medical Group, Inc. (NYSE: MD), a company in the Health Services sector. It states that the market is closed with no trades recorded for this specific financial metric. The article is primarily a data point

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 13:39
Source
TradingView
MarketBeat Direct company coverage

Pediatrix Medical Group (MD) Stock Price, News & Analysis $MD

Pediatrix Medical Group (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal, and pediatric subspecialty care. The company currently has a "Hold" consensus rating from analysts, with a price target of $22.50, suggesting a potenti

Tone
Neutral 50/100
Event
Analyst action
Published
22 Jun 2026 12:10
Source
MarketBeat
AD HOC NEWS Direct company coverage

Pediatrix Medical Group Stock - Weekly move and sector check after quiet news flow

Pediatrix Medical Group (MD) stock saw a modest gain this week with quiet news flow, broadly tracking the US healthcare services sector. The company, which provides physician services in neonatal and maternal-fetal care, is characterized as a defensive healthcare exposure. Its ma

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 17:09
Source
AD HOC NEWS